Journal of Bioequivalence & Bioavailability

International Conference and Exhibiton on Pharmaceutical Regulatory Affairs

6-7 September 2011 Baltimore, USA

Scientific Tracks Abstracts

• Finger printing in low molecular weight heparins for regulating quality and equivalence

  Umesh R. Desai

  PDF HTML

• Cell therapy manufacturing tools and global regulatory environment

  Jiwen Zhang

  PDF HTML

• Successfully meeting the regulatory challenges of abuse/ dependence liability evaluation in the development of new centrally-acting drugs

  David Heal

  PDF HTML

• Study design: How not to ruin a perfectly good product with a perfectly fl awed study design

  Debbie Wilkerson

  PDF HTML

• The importance of investigative site clinical research standard operating procedures (SOPs)

  Gizelle Bak

  PDF HTML

• Antibacterials: Past, Present ? and Future?

  Nafsika H. Georgopapadakou

  PDF HTML

• What is the place of knemometry in development of new inhaled Corticosteroids

  Ole D. Wolthers

  PDF HTML

• Occurrence of adverse drug reactions in the paediatric population

  Lise Aagaard

  PDF HTML

• ?New? drugs and international regulatory mechanisms

  S. V. Eswaran

  PDF HTML

• Current guidelines and detected discrepancy in pharmacy practice care related to medication and patient safety in the population of the blind and deaf-blind

  Miroslav S. Sarac, LaKeisha George Williams

  PDF HTML

• Quality assurance system for Chinese clinical studies of Chinese clinical trials registry

  Taixiang Wu

  PDF HTML

• Management of acute pharyngo tonsillitis according to polish recommendations 2010

  Elzbieta Mazur

  PDF HTML

• Single dose relative bioavailability and safety of a new quetiapine fumarate extended release formulation: Is there a food effect on XR performance

  Francisco E. Estevez-Carrizo

  PDF HTML

• The infrastructure of Ghanaian medicine outlets and its suitability to support public health initiatives and services for malaria control

  Kwame Ohene Buabeng

  PDF HTML

• Vascular protective effects of selective PKCb inhibitor with Ruboxistaurin in Murine models

  Shi-Fang Yan

  PDF HTML

• Molecular mechanisms of Bortezomib adverse effects and drug resistance

  Xinliang Mao

  PDF HTML

• Cell therapy regulations - a critical factor in translational medicine

  Beate Wagner and Reinhard Henschler

  PDF HTML

• Pre-clinical and clinical development of an interferon beta 1a biosimilar for the treatment of multiple sclerosis

  Marcelo Kauffman

  PDF HTML

• The Turkish oncology group efforts to validate the applicability of various chemotherapeutic doses and schedules in Turkish cancer patients

  Nazim Serdar Turhal

  PDF HTML

• Anti-fi brotic actions of suramin: Novel uses of an old drug

  Shougang Zhuang

  PDF HTML

• Drug synergism: The combined effects of fluoxetine and memantine on an animal model of obsessive compulsive disorder

  Raphael Wald

  PDF HTML

• The role of PK/ PD and network analysis in the epidemiology of drug-drug interactions

  Ronald R. Burnette

  PDF HTML

• Regulation of choroidal neovascularisation by tumstatin adenoviral gene delivery and its mechanism(s) action

  Sudhakar Akul Yakkanti

  PDF HTML

• The interaction between clopidogrel and proton pump inhibitors in Japanese patients

  Takeo Yasu

  PDF HTML

• Involvement of GABAA-ergic inhibition and NMDA-ergic excitation in fi negrained temporal processing in audition

  Masashi Sakai

  PDF HTML

• Anti-PSMA antibodies and fragments for diagnosis and therapy of prostate cancer

  Ursula Elsasser-Beile

  PDF HTML

• Preclinical evaluation of a PSMAxCD3 Diabody for therapy of prostate cancer

  Patrick Buhler

  PDF HTML

• Angiotensin type 1 receptors regulate a specifi c set of micro RNA's in cardiovascular tissues including human arteries

  Soren P. Sheikh

  PDF HTML

• Comparison of different mobile phase modifi ers according to their suitability for determination of chromatographic lipophilicity parameters

  Jolanta Flieger

  PDF HTML

• Brazilian toxins targeting channels involved in pain, ischemia and cardiac arrhythmias

  Marcus Vinicius Gomez, A. H. Souza, C. Castro Junior, F.K. Rigo, I.A. Souza, M.A. M. Prado, V.F. Prado, J. Ferreira

  PDF HTML

• Application of nanostructured materials and polymer composite modifi ed electrodes for electrochemical determination of drugs and biomolecules

  Shen Ming Chen

  PDF HTML

• Biosynthesis and diversifi cation of lipoglycopeptide antibiotics

  Tsung-Lin Li

  PDF HTML

• EU biosimilar regulations: An analysis of the data which has underpinned the approval of biosimilars granted marketing authorizations in Europe

  Gary Walsh

  PDF HTML

• From basic research to drug development: The story of Copaxone (glatiramer acetate) in the treatment of multiple sclerosis and its new Applications

  Rina Aharoni

  PDF HTML

• Carbon-nanotubebased fi eld-effect transistors with biosensing functions

  Hu Yan, Hidenori Okuzaki

  PDF HTML

• Eltrombopag as fi rst line treatment for acute radiation syndrome

  Yuhchyau Chen, Jane Liesveld, Lin Gan and David Wu

  PDF HTML

• Human artifi cial chromosome (HAC) vector with a conditional centromere for correction of genetic defi ciencies in human cells

  Natalay Kouprina

  PDF HTML

• New targets for treatment and diagnosis of schizophrenia spectrum disorders

  Tayfun Uzbay

  PDF HTML

• Polymeric prodrugs: Recent achievements and general strategies

  Neeraj Agrawal

  PDF HTML